Arina Martynchyk

8PUBLICATIONS
23CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2026
Toxicity Under-Reporting in Early-Phase Plasma Cell Dyscrasia Clinical Trial Abstracts.

|May 16, 2026
Marked variation in eligibility criteria across registrational trials for relapsed diffuse large B-cell lymphoma limits applicability to clinical practice.

|Apr 08, 2026
Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II 'FLUORO' study.

Arina Martynchyk, Geoffrey Chong, Richard Khor

|Oct 27, 2025
Efficiency and Safety of Brentuximab Vedotine as a Salvage Treatment Before Autologous Stem Cell Transplantation in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma: Retrospective Study.

Kateryna Filonenko, Yana Stepanishyna, Nazar Shokun

|Jun 27, 2025
Refinement of primary central nervous system lymphoma prognostication and response assessment using 3-dimensional MRI.

Jack O'Shaughnessy, Arina Martynchyk, Sze Ting Lee

|Jun 20, 2025
T-cell dysregulation informs radiotherapy-immunotherapy response in B-cell lymphoma: results from a phase 1 trial.

Eliza A Hawkes, Jodie B Palmer, Richard Khor

Pageof 2

Frequent Collaborators

7 joint publications

Eliza A Hawkes

4 joint publications

Geoffrey Chong

2 joint publications

Denise Lee

2 joint publications

Gareth P Gregory